$22.07
0.281.28%
At close: -
$22.10
0.030.14%
After Hours: 5:24 PM EDT
Comments
Loading...
Latest news for Immunovant (NASDAQ:IMVT) Stock
Immunovant Stock (NASDAQ: IMVT)
Categories: All
Friday, January 24, 2025
Wednesday, January 15, 2025
Monday, January 13, 2025
Friday, January 03, 2025
Thursday, December 19, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Tuesday, October 29, 2024
Thursday, October 10, 2024
Wednesday, October 09, 2024
Monday, September 30, 2024
Wednesday, September 11, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
- IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
- Cantor Fitzgerald Reiterates Overweight on Im...
- What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?
- Top 2 Health Care Stocks That May Collapse This Quarter
- Roivant Says Immunovant Reported Results From...
- Immunovant Reports Phase 2a Results for Grave...
Tuesday, August 13, 2024
Thursday, August 08, 2024
Wednesday, August 07, 2024
Tuesday, August 06, 2024
Thursday, June 20, 2024
Tuesday, June 18, 2024
Monday, June 03, 2024
Thursday, May 30, 2024
Wednesday, May 29, 2024
- Immunovant shares are trading lower after the...
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Immunovant Q4 EPS $(0.52) Misses $(0.43) Esti...
- Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
- Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
Thursday, March 28, 2024
Monday, March 25, 2024
Thursday, March 21, 2024
Wednesday, March 13, 2024
Tuesday, March 12, 2024
Thursday, February 15, 2024
Monday, February 12, 2024
Thursday, December 21, 2023
- Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- B of A Securities Maintains Buy on Immunovant...
- Immunovant shares are trading higher after th...
- Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
- Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
- HC Wainwright & Co. Maintains Buy on Immunova...